Drug-Eluting Technologies Clinical Program
Similar Patency with Significantly Less Drug
Boston Scientific is the only company investing in a complete portfolio of drug-eluting therapies, designed to revolutionize the field, as well as ground-breaking pre-clinical and clinical research that are helping define how to better use the technologies.
Boston Scientific Drug Eluting Clinical Program
Favorable twelve-month data for RANGER
RANGER DCB: Clinically proven in both randomized and real-world clinical trials!
MAJESTIC clinical study : Unprecedented Results at 2 years!
WANT TO KNOW MORE?
Join our Drug-Eluting Technologies Community
Sign Up for Product Updates
Receive the latest news of Drug Eluting TechnologiesSIGN UP